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Abstract
Trichodynia is defined as a painful sensation in the skin of the scalp or the hair with-
out an underlying cutaneous disease. The term “trichodynia” (cutaneous dysesthesia 
syndrome) has also been proposed for discomfort, pain, burning, or stinging of the 
scalp related to diffuse alopecia. Probably, the diffuse alopecia or telogen effluvium 
and trichodynia are related. The underlying mechanisms creating the pain are not clear, 
though it has been proposed that it is probably multi-etiological. The most accepted 
hypotheses are increased expression of the neuropeptide substance P, underlying psy-
chiatric disorders, nutritional deficiencies, and perifollicular inflammation. Although 
dealing with trichodynia can be distressing and literature support is weak, there are a 
number of treatments available.
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1. Introduction
Trichodynia is defined as a painful sensation in the skin of the scalp or the hair itself and 
becomes more intense when hairs are touched. Before making a diagnosis of “trichodynia,” 
the physician must be sure that there is no cutaneous disease [1]. If the patient reports head-
ache or temporal pain by palpation, tension headaches or temporal arteritis should be evalu-
ated first. The term “trichodynia” (cutaneous dysesthesia syndrome) has also been proposed 
for discomfort, pain, burning, or stinging of the scalp related to diffuse alopecia. It has been 
found that 34% of female patients with hair loss complained of this phenomenon [2]. In a 
recent survey, Grimalt et al. showed that 14% of their diffuse alopecia patients reported 
trichodynia [3]. Complaints such as pain and burning of the scalp in patients with diffuse 
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alopecia were described in the earlier dermatology literature [2, 4]. Both such studies and 
clinical observations have led to the idea that the diffuse alopecia or telogen effluvium (TE) 
and trichodynia are related. By definition, TE is a nonscarring and diffuse hair loss from the 
scalp that occurs a few months after a triggering event.
2. Ethiopathology
The underlying mechanisms creating the pain are not clear, though it has been proposed that 
it is probably multi-etiological. The most accepted hypotheses are increased expression of 
the neuropeptide substance P (SP), underlying psychiatric disorders, nutritional deficiencies, 
and perifollicular inflammation [1, 2, 5–7]. Substance P is involved in pain perception by the 
nerve endings, and changes in the production and activity of substance P around the hair 
follicles may be responsible for the pain and burning sensation [8]. Hair follicles are inner-
vated by unmyelinated neural plexuses located around the hair follicle stem cells. These nerve 
fibers contain neuropeptides including substance P (SP) and calcitonin gene-related peptide 
(CGRP). These neuropeptides play an important role in the regulation of hair growth and 
are associated with the neurogenic inflammatory response. Perifollicular SP is also involved 
in the regulation of hair growth [9]. An imbalance in the tonic release of neuropeptides may 
result in inhibition of hair growth. Cutrer et al. hypothesized that chronic activation of the 
c-fibers, in addition to mediating inflammatory pain and follicular injury, might reduce SP 
and CGRP concentrations resulting in altered peribulbar antigen presentation and inhibition 
of further hair growth [10].
Another explanation may be an underlying psychiatric disorder. It has been found that 76% 
of the people who had trichodynia had psychopathic signs versus 20% in the control group, 
supporting this idea. Researchers have observed and speculated that there is a connection 
between psychopathologic findings (such as anxiety) and trichodynia [1, 5, 6, 11–14]. In 2006 
Gupta and Gupta. found that numbness and pain are common symptoms of somatoform dis-
sociation or conversion reaction [15]. Kivanç et al. found that trichodynia was associated with 
depression in the telogen alopecia group and with obsessive-compulsive personality disorder 
in the androgenic alopecia group [16]. However, this idea is controversial. Although increased 
rates of psychiatric problems have been reported in patients with trichodynia, Ozturk et al. 
found no association between trichodynia and depression or anxiety [17]. In this study the 
patients with telogen alopecia were consisting the control group, and they could have the 
opportunity to evaluate only the trichodynia patients.
Neuropathic pain can also be associated with nutritional deficiencies (Fe, B12, ferritin, zinc, 
vitamin D, vitamin E). Nutritional factors affect the hair directly, and dietary supplements 
containing B complex vitamins can influence hair growth [17–19]. Nutritional deficiencies 
have been reported in other cutaneous dysesthesia syndromes. For example, glossodynia 
is characterized by a burning sensation of the tongue and oral mucosa. Menopause, psy-
chogenic disorders, and nutritional factors have also been suggested to cause this phenom-
enon [13]. However, evidence level is very low to confirm this nutritional hypothesis for 
trichodynia patients [20].
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3. Treatment
Trichodynia symptoms are of great relevance to patients and place the physician in a chal-
lenging diagnostic and therapeutic situation. Although dealing with trichodynia can 
be distressing and literature support is weak, there are a number of treatments available. 
L-Cystine-containing oral preparations, topical corticosteroids (both high potency and low), 
and anti-inflammatory drugs have been advocated (remember inflammatory hypothesis). 
Inhibitors of SP can also be tried. Cannabinoids, for example, have been demonstrated to 
inhibit SP [21]. Capsaicin cream has been used because it blocks substance P when applied 
to the hair follicles. On the basis of psychiatric origin, the physician also may use low-dose 
antidepressants (venlafaxine, amitriptyline, and doxepin) and also pregabalin [22, 23].
In 2009, Cutrer et al. have investigated the efficacy of botulinum toxin treatment in cephalalgia 
alopecia patients and obtained improved pain control and hair regrowth following BoNT/A 
injections [10]. They also observed that botulinum increases substance P and calcitonin gene-
related peptide-containing cutaneous nerves in the scalp. BoNT/A does not block low-level 
trophic release of neuropeptides such as CGRP and allows resumption of SP and CGRP base-
line regulation of the hair follicle and hair regrowth [24]. However, we should keep in mind 
that BoNT/A treatment is temporary. The process of painful inflammatory activation, hair 
follicle regression, and hair loss is repeated after a few months.
Sensory tests revealed that trichodynia patients were significantly more sensitive to touch 
and to pressure pain and exhibited cranial mechanical hyperesthesia and cranial hyperalge-
sia [25]. So, gentle scalp maintenance may provide some relief. To support the treatment, it 
is important to inform the patients about not to use over hot water and harsh shampoos or 
wear tight pony tail. Other relaxation techniques such as gentle scalp massage may also help 
in reducing symptoms.
4. Other dermatological conditions causing scalp pain
Scalp pain can occur with cicatricial alopecia that can be caused by a fungus infection or auto-
immune conditions such as cutaneous lupus and lichen planopilaris. Folliculitis decalvans 
and dissecting cellulitis are forms of primary neutrophilic scarring alopecia that are char-
acterized clinically by chronic suppurative folliculitis and often associated with pruritus or 
even pain. The inflammatory cells may irritate nerve endings leading to a burning or painful 
sensation. Hair dye-related dermatitis may also cause burning sensations.
There are also painful tumoral lesions of the skin and subcutaneous tissue. These lesions can 
be found anywhere in the peripheral nerve tissue. They have a propensity for developing on 
the skin and subcutaneous tissue, as well as in oral and pharyngeal locations. An old acronym 
may help us to remember them. LEND AN EGG tumors (leiomyoma, eccrine spiradenoma, 
neuroma, dermatofibroma, angiolipoma, neurilemmoma, endometrioma, glomus tumor, and 
granular cell tumors) must always be considered when there is a tumoral lesion associated 
with pain [26].
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